te healthcare system could be improved. To ensure adequate IDA management and prompt resolution of iron deficiency anaemia, we recommended the need to review the Namibia Standard Treatment guidelines and to ensure that training on the guidelines is offered. Hyaluronic acid fillers are gaining popularity all across the globe. https://www.selleckchem.com/Androgen-Receptor.html Although this aesthetic treatment is considered relatively safe, or that most unwanted effects are related to technical faults of the injections or infections, hypersensitivity reactions are being reported in acute or delayed forms. We herein describe an unusual case of hypersensitivity reaction to hyaluronic acid dermal fillers of 12-month latency, manifesting as cutaneous and visceral angioedema, and refractory to steroids, antihistamines and omalizumab. We aim to raise awareness of delayed hypersensitivity reactions to hyaluronic acid fillers since patients often unaware due to the time lapse from the procedure. A 47-year-old female, presenting with cutaneous and visceral angioedema 12months after uneventful injection of hyaluronic acid-based dermal fillers. Angioedema was refractory to systemic steroids, antihistamines and omalizumab. Symptoms resolved miraculously after dissolving the fillers with hyaluronidase. In almost all previously described cases of late-onset response to hyaluronic acid dermal fillers, swelling was restricted to the treated area, was responsive to steroids or required no intervention at all. To our knowledge, this is an unusual case of hypersensitivity reaction to hyaluronic acid dermal fillers of 12-month latency, manifesting as refractory cutaneous and visceral angioedema. In almost all previously described cases of late-onset response to hyaluronic acid dermal fillers, swelling was restricted to the treated area, was responsive to steroids or required no intervention at all. To our knowledge, this is an unusual case of hypersensitivity reaction to hyaluronic acid dermal fillers of 12-month latency, manifesting as refractory cutaneous and visceral angioedema. Permanent pacemaker (PPM) and implantable cardioverter defibrillator (ICD) implant rates have increased in New Zealand over the past decade. This study aims to provide a contemporary analysis of regional variation in implant rates. New PPM and ICD implants in patients ≥15 years were identified for ten years (2009 to 2018) using procedure coding in the National Minimum Datasets, which collects all New Zealand public hospital admissions. Age-standardised new implant rates per million adult population were calculated for each of the four regions (Northern, Midland, Central and Southern) and the 20 district health boards (DHBs) across those regions. Trend analysis was performed using joinpoint regression. New PPM implant rates increased nationally by 3.4%/year (p < 0.001). The Northern region had the highest new PPM implant rate, increasing by 4.5%/year (p < 0.001). Excluding DHBs with <50 000 people, the new PPM implant rate for 2017/2018 was highest in Counties Manukau DHB (854.3/million, 95% CI 774.9-933.6/million) and lowest in Canterbury DHB (488.6/million, 95% CI 438.1-539.0/million). New ICD implant rates increased nationally by 3.0%/year (p=0.002). The Midland region had the highest new ICD implant rate, increasing by 3.8%/year (p=0.013). Excluding DHBs with <50 000 people, the new ICD implant rate for 2017/2018 was highest in Bay of Plenty DHB (228.5/million, 95% CI 180.4-276.6/million) and lowest in Canterbury DHB (90.2/million, 95% CI 69.9-110.4/million). There was significant variation in PPM and ICD implant rates across regions and DHBs, suggesting potential inequity in patient access across New Zealand. This article is protected by copyright. All rights reserved. There was significant variation in PPM and ICD implant rates across regions and DHBs, suggesting potential inequity in patient access across New Zealand. This article is protected by copyright. All rights reserved.Recent advances in the recognition of biological samples using machine vision have made this technology increasingly important in research and detection. Image segmentation is an important step in this process. This study focuses on how to reduce the interference factors such as the overlap between different types (or within the same type) of urine cells according to microfluidics and improve the machine vision segmentation accuracy for cell images. In this study, we demonstrate that the platform can realize this hypothesis using urine cell image segmentation as an example application. We first discuss the reported urine cell droplet microfluidic chip system, which can realize the test conditions in which urine cells are encapsulated in the droplet and isolated from salt crystallization and/or bacteria and other urine-formed elements. Then, based on the analysis conditions set in the aforementioned experiment, the proportions of red blood cells, white blood cells, and squamous epithelial cells covered by various formed elements in the total urine cells in the same urine sample are measured. We simultaneously analyze the percentage of urine cells covered by salt crystallization and the incidence of overlapping between urine cells. Finally, the Otsu algorithm is used to segment the urine cell images encapsulated by the droplet and the urine cell images not encapsulated by the droplet, and the Dice, Jaccard, precision, and recall values are calculated. The results suggest that the method of encapsulating single cells based on droplets can improve the image segmentation effect without optimizing the algorithm.Polyunsaturated fatty acids (PUFAs) are essential in healthy diets and their production is extremely important. Natural sources of PUFAs includes animal and aquatic products such as marine fish oil, however there are several limitations such as the decrease of fish stocks throughout the world. Thus, microbial oils are a preferable source of PUFAs. Herein, it was studied the production of PUFAs by Mortierella alpina under solid-state fermentation (SSF) using polyurethane foam as inert substrate and synthetic medium or lignocellulosic hydrolysate as source of C, N, and other nutrients. Several parameters of fermentation conditions were evaluated as carbon source, inductors addition, ratio C/N and temperature. The highest amount of total PUFAs per mass of solid (535.41 ± 24.12 mg/g), linoleic acid (129.66 ± 5.84 mg/g), and α-linoleic acid (401.93 ± 18.10 mg/g) were produced when the culture medium contained 20 g/L glucose, 10% (w/v) linseed oil, the C/N ratio was adjusted to 25 and the incubation temperature was 25°C for 3 days decreasing to 16°C on the remaining 4 days of fermentation.